BE659329A - - Google Patents

Info

Publication number
BE659329A
BE659329A BE659329A BE659329A BE659329A BE 659329 A BE659329 A BE 659329A BE 659329 A BE659329 A BE 659329A BE 659329 A BE659329 A BE 659329A BE 659329 A BE659329 A BE 659329A
Authority
BE
Belgium
Application number
BE659329A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE659329A publication Critical patent/BE659329A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/80—Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BE659329A 1964-02-07 1965-02-05 BE659329A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR963087A FR1408721A (fr) 1964-02-07 1964-02-07 Dérivés du furanne et leur préparation

Publications (1)

Publication Number Publication Date
BE659329A true BE659329A (ja) 1965-08-05

Family

ID=8822720

Family Applications (1)

Application Number Title Priority Date Filing Date
BE659329A BE659329A (ja) 1964-02-07 1965-02-05

Country Status (9)

Country Link
US (1) US3355463A (ja)
BE (1) BE659329A (ja)
BR (1) BR6566852D0 (ja)
DE (1) DE1493626B2 (ja)
DK (1) DK114699B (ja)
FR (1) FR1408721A (ja)
GB (1) GB1092695A (ja)
NL (2) NL6501095A (ja)
SE (1) SE325901B (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3484457A (en) * 1968-03-15 1969-12-16 Bristol Myers Co Certain spiro butyrolactones
AP2005003232A0 (en) 2002-08-19 2005-03-31 Pfizer Prod Inc Combination therapy for hyperproliferative diseases.
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
US8404896B2 (en) 2006-12-01 2013-03-26 Bristol-Myers Squibb Company N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases
BR112015026513A2 (pt) 2013-04-17 2017-07-25 Pfizer derivados de n-piperidin-3-ilbenzamida para tratar as doenças cardiovasculares
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
MX2021008533A (es) 2019-01-18 2021-08-19 Astrazeneca Ab Inhibidores de la pcsk9 y metodos de uso de los mismos.

Also Published As

Publication number Publication date
US3355463A (en) 1967-11-28
GB1092695A (en) 1967-11-29
DE1493626B2 (de) 1973-05-30
NL6501095A (ja) 1965-08-09
SE325901B (ja) 1970-07-13
FR1408721A (fr) 1965-08-20
DE1493626A1 (de) 1969-07-17
DK114699B (da) 1969-07-28
NL128190C (ja)
BR6566852D0 (pt) 1973-02-22

Similar Documents

Publication Publication Date Title
AU4679664A (ja)
BE642530A (ja)
BE642243A (ja)
BE432268A (ja)
BE47396A (ja)
BE659329A (ja)
BE507097A (ja)
BE518974A (ja)
BE554195A (ja)
BE564626A (ja)
BE584699A (ja)
BE603534A (ja)
BE610935A (ja)
BE613833A (ja)
BE621510A (ja)
BE622126A (ja)
BE623398A (ja)
BE626083A (ja)
BE626684A (ja)
BE627057A (ja)
BE627390A (ja)
BE627931A (ja)
BE628611A (ja)
BE629793A (ja)
BE632875A (ja)